Style | Citing Format |
---|---|
MLA | Kakavandi E, et al.. "Evaluation of Angiotensin Converting Enzyme 2 (Ace2), Angiotensin Ii (Ang Ii), Mir-141-3P, and Mir-421 Levels in Sars-Cov-2 Patients: A Case-Control Study." BMC Infectious Diseases, vol. 24, no. 1, 2024, pp. -. |
APA | Kakavandi E, Sadeghi K, Shayestehpour M, Mirhendi H, Rahimi Foroushani A, Mokhtariazad T, Shafiei Jandaghi NZ, Yavarian J (2024). Evaluation of Angiotensin Converting Enzyme 2 (Ace2), Angiotensin Ii (Ang Ii), Mir-141-3P, and Mir-421 Levels in Sars-Cov-2 Patients: A Case-Control Study. BMC Infectious Diseases, 24(1), -. |
Chicago | Kakavandi E, Sadeghi K, Shayestehpour M, Mirhendi H, Rahimi Foroushani A, Mokhtariazad T, Shafiei Jandaghi NZ, Yavarian J. "Evaluation of Angiotensin Converting Enzyme 2 (Ace2), Angiotensin Ii (Ang Ii), Mir-141-3P, and Mir-421 Levels in Sars-Cov-2 Patients: A Case-Control Study." BMC Infectious Diseases 24, no. 1 (2024): -. |
Harvard | Kakavandi E et al. (2024) 'Evaluation of Angiotensin Converting Enzyme 2 (Ace2), Angiotensin Ii (Ang Ii), Mir-141-3P, and Mir-421 Levels in Sars-Cov-2 Patients: A Case-Control Study', BMC Infectious Diseases, 24(1), pp. -. |
Vancouver | Kakavandi E, Sadeghi K, Shayestehpour M, Mirhendi H, Rahimi Foroushani A, Mokhtariazad T, et al.. Evaluation of Angiotensin Converting Enzyme 2 (Ace2), Angiotensin Ii (Ang Ii), Mir-141-3P, and Mir-421 Levels in Sars-Cov-2 Patients: A Case-Control Study. BMC Infectious Diseases. 2024;24(1):-. |
BibTex | @article{ author = {Kakavandi E and Sadeghi K and Shayestehpour M and Mirhendi H and Rahimi Foroushani A and Mokhtariazad T and Shafiei Jandaghi NZ and Yavarian J}, title = {Evaluation of Angiotensin Converting Enzyme 2 (Ace2), Angiotensin Ii (Ang Ii), Mir-141-3P, and Mir-421 Levels in Sars-Cov-2 Patients: A Case-Control Study}, journal = {BMC Infectious Diseases}, volume = {24}, number = {1}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Kakavandi E AU - Sadeghi K AU - Shayestehpour M AU - Mirhendi H AU - Rahimi Foroushani A AU - Mokhtariazad T AU - Shafiei Jandaghi NZ AU - Yavarian J TI - Evaluation of Angiotensin Converting Enzyme 2 (Ace2), Angiotensin Ii (Ang Ii), Mir-141-3P, and Mir-421 Levels in Sars-Cov-2 Patients: A Case-Control Study JO - BMC Infectious Diseases VL - 24 IS - 1 SP - EP - PY - 2024 ER - |